Pediatric vestibular migraine: Diagnosis according to ICHD-3 criteria and the effectiveness of short-term CH prophylaxis

dc.authoridCETIN, HURIYE/0000-0002-7911-9981
dc.authoridCokyaman, Turgay/0000-0002-7108-6839
dc.contributor.authorCokyaman, Turgay
dc.contributor.authorCetin, Huriye
dc.date.accessioned2025-01-27T21:04:15Z
dc.date.available2025-01-27T21:04:15Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: Vestibular migraine (VM) is a rare migraine variant with limited information about its treatment in children. This study, it was aimed to evaluate the diagnostic characteristics of VM in children and the effectiveness of cyproheptadine hydrochloride (CH) prophylaxis. Methods: Patients aged 6-18 years who were diagnosed with VM and other primary headaches (OPHs) according to ICHD-3 diagnostic criteria and given oral CH prophylaxis for at least 3 months were included in the study. Response to CH prophylaxis was defined by the change in symptoms (worsening, no change, and improvement) monthly. Results: A total of 64 cases diagnosed with primary headache and given CH prophylaxis were identified. 40.6% (29) migraine without aura of patients, 34.4% (22) VM, 14.1% (9) tension type headache, 4.7% (3) benign paroxysmal vertigo, 3.1% (2) migraine with aura and 3.1% (2) were diagnosed with abdominal migraine. Compared to OPHs, it was found that the duration of headache attack was shorter (p .013) and vomiting, which is one of the associated symptoms, was observed less in pediatric VM (p .032). The positive response of the whole study population to CH prophylaxis was 85.9%. However, CH prophylaxis responses were higher in VM compared to OPHs at the end of 1 month (63.6%) and 2 months (86.3%). Conclusion: In the pediatric population, the migrainous characters of VM may show differences, but its response to short-term CH prophylaxis is quite good.
dc.identifier.doi10.1016/j.ejpn.2022.05.002
dc.identifier.endpage24
dc.identifier.issn1090-3798
dc.identifier.issn1532-2130
dc.identifier.pmid35636099
dc.identifier.scopus2-s2.0-85130523220
dc.identifier.scopusqualityQ1
dc.identifier.startpage19
dc.identifier.urihttps://doi.org/10.1016/j.ejpn.2022.05.002
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27592
dc.identifier.volume39
dc.identifier.wosWOS:000806371700002
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofEuropean Journal of Paediatric Neurology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectVertigo
dc.subjectMigraine
dc.subjectChildren
dc.subjectVestibular migraine
dc.titlePediatric vestibular migraine: Diagnosis according to ICHD-3 criteria and the effectiveness of short-term CH prophylaxis
dc.typeArticle

Dosyalar